Magenta Therapeutics, Inc.

Magenta Therapeutics, Inc.verified

MGTA

Price:

$0.6996

Market Cap:

$42.44M

Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that cause acute myeloid leukemia and myelodysplastic syndromes, which is under Phase I/II clinical trial; CD45-antibody drug conjugate that targets HSCs and immune cells, which is in investigational new drug application enabling studies for potential use as a single-agent in autoimmune diseases and hematology-oncology transplants; and MGTA-145 that is in Ph...[Read more]

Industry

Biotechnology

IPO Date

2018-06-21

Stock Exchange

NASDAQ

Ticker

MGTA

The PE Ratio as of May 2024 (TTM) for Magenta Therapeutics, Inc. (MGTA) is -0.61

According to Magenta Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.61. This represents a change of 807.78% compared to the average of -0.07 of the last 4 quarters.

Magenta Therapeutics, Inc. (MGTA) Historical PE Ratio (quarterly & annually)

How has MGTA PE Ratio performed in the past?

The mean historical PE Ratio of Magenta Therapeutics, Inc. over the last ten years is -6.13. The current -0.61 PE Ratio has changed 892.77% with respect to the historical average. Over the past ten years (40 quarters), MGTA's PE Ratio was at its highest in in the December 2022 quarter at -0.01. The PE Ratio was at its lowest in in the March 2017 quarter at -16.22.

Quarterly (TTM)
Annual

Average

-6.13

Median

-0.26

Minimum

-33.10

Maximum

-0.02

Magenta Therapeutics, Inc. (MGTA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Magenta Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 348.01%

Maximum Annual PE Ratio = -0.02

Minimum Annual Increase = -98.91%

Minimum Annual PE Ratio = -33.10

Quarterly (TTM)
Annual
YearPE RatioChange
2022-0.02-91.23%
2021-0.20-25.39%
2020-0.26-39.05%
2019-0.43348.01%
2018-0.10-98.91%
2017-8.80-73.43%

Magenta Therapeutics, Inc. (MGTA) Average PE Ratio

How has MGTA PE Ratio performed in the past?

The current PE Ratio of Magenta Therapeutics, Inc. (MGTA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.16

5-year avg

-0.20

10-year avg

-6.13

Magenta Therapeutics, Inc. (MGTA) PE Ratio vs. Peers

How is MGTA’s PE Ratio compared to its peers?

Magenta Therapeutics, Inc.’s PE Ratio is greater than Assembly Biosciences, Inc. (-1.55), less than Instil Bio, Inc. (-0.61), greater than Nuvation Bio Inc. (-10.56), less than Achilles Therapeutics plc (-0.59), greater than NextCure, Inc. (-0.73), less than Spero Therapeutics, Inc. (3.64), greater than Neoleukin Therapeutics, Inc. (-0.98), less than CytomX Therapeutics, Inc. (9.38),

Build a custom stock screener for Magenta Therapeutics, Inc. (MGTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Magenta Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Magenta Therapeutics, Inc. (MGTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Magenta Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Magenta Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Magenta Therapeutics, Inc. (MGTA)?

What is the highest PE Ratio for Magenta Therapeutics, Inc. (MGTA)?

What is the 3-year average PE Ratio for Magenta Therapeutics, Inc. (MGTA)?

What is the 5-year average PE Ratio for Magenta Therapeutics, Inc. (MGTA)?

How does the current PE Ratio for Magenta Therapeutics, Inc. (MGTA) compare to its historical average?